CVD weekly pick
2026 ACC/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.
Journal of the American College of Cardiology. 2026 Jan 8;:.
0
Corrigendum to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%): [Canadian Journal of Cardiology. Volume 41, Issue 10, October 2025, Pages 1857-1874. doi:10.1016/j.cjca.2025.07.027].
The Canadian journal of cardiology. 2026 Jan 6;:.
0
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial.
JAMA. 2026 Jan 13;335(2):129-139.
0
ACC/AHA vs ESC/EACT Guidelines on valvular heart disease: EJPC Guideline comparison review.
European journal of preventive cardiology. 2026 Jan 12;:.
0
Sacubitril/Valsartan vs Enalapril in Heart Failure Due to Chagas Disease: An Open-Label, Multicenter Randomized Clinical Trial.
JAMA. 2026 Jan 6;335(1):49-59.
0
Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation.
Circulation. 2026 Jan 6;153(1):35-46.
0
The Role of Lipoprotein(a) in Cardiovascular Risk Stratification: Integrating Low-density Lipoprotein Cholesterol and Polygenic Risk Scores.
The American journal of cardiology. 2026 Jan 15;259:116-122.
0
[Interventional cardiology : what's new in 2025].
Revue medicale suisse. 2026 Jan 14;22(945):19-24.
0
Implantable Cardioverter-Defibrillator and Frailty in Non-ischemic Heart Failure With Reduced Ejection Fraction: Extended Follow-Up of the DANISH Trial.
The American journal of cardiology. 2026 Jan 15;259:163-172.
0
Evolution and Prognostic Value of Right Ventricular to Pulmonary Artery Coupling During Guideline-Directed Medical Therapy Up-Titration.
Circulation. Heart failure. 2026 Jan 7;:e012980.
0
Heart Failure Guideline-Directed Medical Therapy After TAVR: Completing the Journey From Valve to Ventricle.
JACC. Cardiovascular interventions. 2026 Jan 12;19(1):59-62.
0
Rewriting Diabetes Therapy: How Incretin Modulation is Transforming Cardiovascular and Renal Outcomes.
Diabetes therapy : research, treatment and education of diabetes and related disorders. 2026 Jan 5;:.
0
Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection Fraction.
JACC. Cardiovascular interventions. 2026 Jan 12;19(1):47-58.
0
Consensus Statement on Optimisation of Patient Care After Hospitalisation for Acute Heart Failure.
Heart, lung & circulation. 2026 Jan 14;:.
0
Repeatability and quality assessment of QFR in the FAVOR III Europe trial: the REPEAT-QFR study.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2026 Jan 5;22(1):e53-e65.
0
Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score.
European heart journal. 2026 Jan 5;47(1):94-106.
0
The DIGIT-HF trial and the Mihai Gheorghiade legacy: time to reconsider cardiac glycosides as effective therapy in HFrEF.
Heart failure reviews. 2026 Jan 9;31(1):18.
0
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association.
European heart journal. 2026 Jan 5;47(1):22-36.
0
Subacute coronary artery occlusion: complexities of the grey zone.
European heart journal. 2026 Jan 6;:.
0
Recent-onset atrial fibrillation: challenges and opportunities.
European heart journal. 2026 Jan 7;47(2):170-187.
0